Brexit uncertainty leaves companies ‘having to prepare for every scenario’, says BIA
BioIndustry Association, a trade organisation for bioindustry, has voiced its frustration at the lack of clarity facing those in the industry over Brexit.
Archives for July 6, 2018
NEWS IN BRIEF
US FDA approves first neurotoxin for chronic sialorrhea
The US FDA has approved Merz’s Xeomin as the first and only neurotoxin available to treat chronic sialorrhea.
MassBio condemns US travel ban: ‘The life sciences industry thrives because of immigrants’
President Trump’s immigration travel ban will deny pharmaceutical companies the opportunity to hire the ‘best and brightest,’ says Massachusetts Biotechnology Council CEO.